Clicky

Investor

Relief Therapeutics to Participate in Industry and Investor Conferences in May
440 386 Rick

GENEVA, SWITZERLAND / ACCESSWIRE / May 9, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (“Relief“), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announced participation in the…

  • Rick
  • 0
  • 0

NLS Pharmaceutics to Participate in the B. Riley Annual Neuro & Ophthalmology Investor Conference
1000 260 Riley

NLS Pharmaceutics Ltd. is a Swiss clinical-stage biopharmaceutical company led by an experienced management team with a track record of developing and repurposing product candidates to treat rare and complex central nervous system disorders. The…

  • Riley
  • 0
  • 0

Celcuity to Participate in Upcoming Needham and Canaccord Genuity Investor Conferences
508 163 George

MINNEAPOLIS, MN / ACCESSWIRE / April 5, 2022 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing an integrated therapeutic and companion diagnostic strategy for treating patients with cancer, today announced that Brian Sullivan, Chairman, Chief Executive…

  • George
  • 0
  • 0

Due to Investor Demand iMetal Increases Size of Private Placement
168 82 Rick

VANCOUVER, BC / ACCESSWIRE / March 25, 2022 / iMetal Resources Inc. (TSXV:IMR) (OTC PINK:ADTFF) (FRA:A7V2) (“iMetal” or the “Company“) announces that as a result of market interest it has elected to increase the size…

  • Rick
  • 0
  • 0
  • 1
  • 2